Chemed Corp
NYSE:CHE
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
525.03
650.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CHE stock under the Base Case scenario is 503.31 USD. Compared to the current market price of 570.96 USD, Chemed Corp is Overvalued by 12%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Chemed Corp
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CHE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Chemed Corp
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Chemed Corp. is a distinguished player in the healthcare sector, known primarily for its two main subsidiaries: VITAS Healthcare and Chemed Home Health. VITAS is the nation’s leading provider of hospice and palliative care services, which cater to patients with life-limiting illnesses. This segment underscores Chemed’s dedication to enhancing the quality of life for patients and their families, focusing on compassionate care and support during critical times. Operating in a market increasingly underpinned by an aging population and a growing preference for home-based healthcare solutions, Chemed stands to benefit from favorable demographic trends. In addition, its Chemed Home Health division...
Chemed Corp. is a distinguished player in the healthcare sector, known primarily for its two main subsidiaries: VITAS Healthcare and Chemed Home Health. VITAS is the nation’s leading provider of hospice and palliative care services, which cater to patients with life-limiting illnesses. This segment underscores Chemed’s dedication to enhancing the quality of life for patients and their families, focusing on compassionate care and support during critical times. Operating in a market increasingly underpinned by an aging population and a growing preference for home-based healthcare solutions, Chemed stands to benefit from favorable demographic trends. In addition, its Chemed Home Health division positions the company well within the rapidly expanding home healthcare market, facilitating personalized care in a familiar environment, which has shown significant promise in improving patient outcomes.
For investors, Chemed Corp. offers a compelling investment narrative characterized by steady growth, financial stability, and a robust operational model. The company has demonstrated strong revenue generation and consistently high margins, reflective of its effective management and operational efficiencies. With a solid balance sheet and commitment to shareholder returns, Chemed has a track record of delivering value through dividends and strategic reinvestments. Moreover, as healthcare policies increasingly favor in-home care solutions and as demographics shift towards an older population, Chemed is poised to capture considerable market opportunities. Its proven ability to adapt to changing healthcare needs not only underlines its resilience but also highlights its potential for sustained financial performance and long-term growth.
Chemed Corporation operates primarily through two core business segments:
-
VITAS Healthcare: This segment is a leading provider of hospice care services in the United States. VITAS provides medical, emotional, and spiritual support to patients with terminal illnesses and their families, focusing on palliative care. Their services include in-home care, as well as care in assisted living and nursing facilities. VITAS emphasizes a patient-centered approach, providing a multidisciplinary team of professionals to manage symptoms and improve quality of life for patients in their last stages of life.
-
Roto-Rooter: This segment is primarily focused on plumbing and drain cleaning services. Roto-Rooter is a well-known brand in the United States and Canada, offering both residential and commercial plumbing services. The company operates a network of franchises and company-owned locations, providing services such as emergency plumbing repairs, drain cleaning, and installation of plumbing fixtures. Roto-Rooter also offers maintenance services aimed at preventing plumbing issues before they occur.
Together, these two segments position Chemed Corporation as a notable player in both healthcare and service industries, with a commitment to quality service and customer satisfaction. These segments also allow Chemed to diversify its revenue streams, catering to different customer needs in the healthcare and home services markets.
Chemed Corporation, which operates primarily through its subsidiaries VITAS Healthcare and Chemed's Roto-Rooter plumbing and drain services, has several unique competitive advantages that help differentiate it from its rivals. Here are some key factors:
-
Strong Brand Equity: Chemed has established a strong brand presence in both its healthcare and plumbing divisions. VITAS Healthcare is recognized as a leader in the hospice care sector, known for high-quality patient care and strong emotional support for families.
-
Integrated Services: Chemed provides integrated hospice and palliative care services through VITAS, which allows for a cohesive care experience for patients and families. This integration often translates into better patient outcomes, which can be a significant selling point against competitors.
-
Experienced Management Team: Chemed boasts a seasoned management team with extensive experience in the healthcare and service industries. Their ability to navigate regulatory environments, particularly in the highly regulated healthcare sector, offers a competitive edge.
-
Patient-Centric Care Model: VITAS' focus on individualized care and comprehensive support services helps foster strong patient and caregiver relationships, leading to better satisfaction scores and potential referrals.
-
Earnings Stability: Chemed operates in sectors that tend to have more stable demand, such as hospice care, which is less susceptible to economic downturns. This stability can help maintain profitability and provide a reliable investment in uncertain times.
-
Strong Financial Position: Chemed has demonstrated solid financial performance with consistent cash flows. This provides the company with the ability to invest in growth opportunities, technology, and infrastructure improvements, giving it an edge over competitors with weaker financial standings.
-
Strategic Acquisitions: Chemed has a history of pursuing strategic acquisitions to expand its service capacity and geographic reach in both its hospice and plumbing segments. This strategy allows it to respond quickly to market demands and consolidate its position in the industry.
-
Technological Adoption: Chemed invests in technology to enhance service delivery, improve patient management systems, and streamline operations. This can lead to efficiencies and improved service quality compared to competitors who may be slower to adopt new technologies.
-
Regulatory Compliance Expertise: Especially in the healthcare space, Chemed's depth of knowledge regarding regulatory compliance gives it an advantage in maintaining quality standards and avoiding costly penalties that competitors might face.
By leveraging these competitive advantages, Chemed Corporation is positioned effectively against its rivals, allowing it to sustain its market presence and grow over time.
Chemed Corporation, which operates primarily in the healthcare sector through its subsidiaries, including VITAS Healthcare and Roto-Rooter, faces several risks and challenges:
-
Regulatory Changes: The healthcare industry is heavily regulated, and any changes in regulations or reimbursement policies, especially concerning hospice care and home health services, could impact Chemed's operations and profitability.
-
Market Competition: The hospice and home health care markets are competitive. New entrants or existing competitors might innovate or offer lower-cost services, which could erode Chemed's market share.
-
Reimbursement Risks: Chemed relies on Medicare and Medicaid for a significant portion of its revenue. Changes in reimbursement rates or policies from these programs can directly affect financial performance.
-
Labor Shortages: The healthcare sector is experiencing workforce shortages, particularly in nursing and healthcare support roles. Finding and retaining qualified personnel is critical to providing quality care and maintaining operational efficiency.
-
Economic Conditions: Economic downturns can affect consumer spending and may lead to a reduction in demand for certain services, as patients or families may be less willing or able to seek care.
-
Litigation Risks: As with many healthcare providers, Chemed may face lawsuits related to patient care or employment practices. Legal challenges can result in significant costs and potentially damage the company’s reputation.
-
Technological Disruption: Continued advancements in technology, such as telehealth solutions and electronic health records, require ongoing investments. Failure to adapt to these changes could hinder competitiveness.
-
Aging Population: While an aging population generally increases demand for hospice and home health services, it also necessitates a scalable response from Chemed to meet this demand in various regions effectively.
-
COVID-19 and Health Pandemics: Ongoing concerns related to health pandemics could impact operations, staffing, and patient care, necessitating additional resources and adaptations in service delivery.
-
Consolidation in Healthcare: The trend towards consolidation in the healthcare market could lead to larger competitors acquiring market share or negotiating better reimbursement rates, creating challenges for Chemed.
-
Reputation Management: Maintaining a positive reputation in the healthcare industry is vital. Negative reviews, patient experiences, or any negative media coverage could have a lasting impact on patient acquisition and retention.
Addressing these risks requires a proactive and adaptive strategic approach, focusing on regulatory compliance, enhancing service quality, improving operational efficiencies, and investing in workforce development.
Revenue & Expenses Breakdown
Chemed Corp
Balance Sheet Decomposition
Chemed Corp
Current Assets | 490.4m |
Cash & Short-Term Investments | 238.5m |
Receivables | 196.5m |
Other Current Assets | 55.5m |
Non-Current Assets | 1.3B |
Long-Term Investments | 126.6m |
PP&E | 335.1m |
Intangibles | 761.6m |
Other Non-Current Assets | 55.7m |
Current Liabilities | 264.8m |
Accounts Payable | 44.9m |
Accrued Liabilities | 175.9m |
Other Current Liabilities | 43.9m |
Non-Current Liabilities | 268.9m |
Other Non-Current Liabilities | 268.9m |
Earnings Waterfall
Chemed Corp
Revenue
|
2.4B
USD
|
Cost of Revenue
|
-1.5B
USD
|
Gross Profit
|
847.8m
USD
|
Operating Expenses
|
-446.6m
USD
|
Operating Income
|
401.2m
USD
|
Other Expenses
|
-99.5m
USD
|
Net Income
|
301.7m
USD
|
Free Cash Flow Analysis
Chemed Corp
USD | |
Free Cash Flow | USD |
In Q3 2024, VITAS Healthcare reported net revenues of $391.4 million, a 17.3% increase driven by higher admissions and a Medicare reimbursement rate rise. Adjusted EBITDA climbed 33.1% to $73.1 million, reflecting a solid margin of 18.6%. Conversely, Roto-Rooter’s revenues fell 6.9% to $214.8 million, with residential demand significantly down. Full-year EPS guidance for Chemed is now projected between $23.00 and $23.15, 13.3% to 14% above last year, as challenges in Roto-Rooter's sector continue. Expectations for VITAS in 2025 include continued strong growth, targeting high single to low double-digit increases in care days.
What is Earnings Call?
CHE Profitability Score
Profitability Due Diligence
Chemed Corp's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
Chemed Corp's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
CHE Solvency Score
Solvency Due Diligence
Chemed Corp's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Chemed Corp's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CHE Price Targets Summary
Chemed Corp
According to Wall Street analysts, the average 1-year price target for CHE is 676.94 USD with a low forecast of 639.33 USD and a high forecast of 743.4 USD.
Dividends
Current shareholder yield for CHE is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
CHE Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Chemed Corp. engages in the provision of healthcare and maintenance services. The company is headquartered in Cincinnati, Ohio and currently employs 14,137 full-time employees. The Company’s segments include VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. The firm's VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The firm services are provided through a network of Company-owned branches, independent contractors, and franchisees. The firm operates through its two wholly owned subsidiaries VITAS Healthcare Corporation and Roto-Rooter Group, Inc.
Contact
IPO
Employees
Officers
The intrinsic value of one CHE stock under the Base Case scenario is 503.31 USD.
Compared to the current market price of 570.96 USD, Chemed Corp is Overvalued by 12%.